Literature DB >> 15710504

Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.

Vitali Vogel1, Dirk Lochmann, Jörg Weyermann, Gottfried Mayer, Christos Tziatzios, Jacomina A van den Broek, Winfried Haase, Daan Wouters, Ulrich S Schubert, Jörg Kreuter, Andreas Zimmer, Dieter Schubert.   

Abstract

Oligodesoxynucleotides (ODNs) or the corresponding phosphorothioates (PTOs) spontaneously form spherical nanoparticles ("proticles") with protamine in aqueous solutions. The proticles can cross cellular membranes and release the ODNs within the cells. Thus, they represent a potential drug delivery system. The major disadvantages of this system are a lack of stability in salt solutions and its inability to also release PTOs. The present study shows, using PTOs and protamine free base, that these shortcomings can be eliminated by the addition of human serum albumin (HSA) as a third component to the starting mixture. The "ternary" proticles thus obtained contain maximally a few percent of the HSA that was originally present. Nevertheless, they differ from the previously studied "binary" proticles: (1) They are stable in salt solutions for at least several hours. (2) They show a high cellular uptake into murine fibroblasts, and they readily release the PTOs after uptake. The ternary proticles therefore represent a considerable improvement over binary proticles for use as drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710504     DOI: 10.1016/j.jconrel.2004.11.029

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

Review 1.  Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2011-07

Review 2.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

3.  Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.

Authors:  Akhtar Siddiqui; Gauri Anand Patwardhan; Yong-Yu Liu; Sami Nazzal
Journal:  Int J Pharm       Date:  2010-09-15       Impact factor: 5.875

4.  Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.

Authors:  Tianzhi Yang; Alamdar Hussain; Shuhua Bai; Ikramy A Khalil; Hideyoshi Harashima; Fakhrul Ahsan
Journal:  J Control Release       Date:  2006-08-30       Impact factor: 9.776

Review 5.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

6.  EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins.

Authors:  Johannes Winkler; Patricia Martin-Killias; Andreas Plückthun; Uwe Zangemeister-Wittke
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

Review 8.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

9.  Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.

Authors:  Bernhard Scheicher; Cornelia Lorenzer; Katrin Gegenbauer; Julia Partlic; Fritz Andreae; Alexander H Kirsch; Alexander R Rosenkranz; Oliver Werzer; Andreas Zimmer
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

10.  Antimicrobial peptide AR-23 derivatives with high endosomal disrupting ability enhance poly(l-lysine)-mediated gene transfer.

Authors:  Shi-Kun Zhang; Lin Gong; Xue Zhang; Zhi-Min Yun; Su-Bo Li; Hong-Wei Gao; Cong-Jie Dai; Jian-Jun Yuan; Jing-Ming Chen; Feng Gong; Ying-Xia Tan; Shou-Ping Ji
Journal:  J Gene Med       Date:  2020-08-28       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.